Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
2668PDF: 1732HTML: 3624Pellagatti Fig 1: 182Pellagatti Fig. 2: 182 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1826PDF: 816HTML: 1224 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1847PDF: 1042HTML: 553 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3640PDF: 1406HTML: 456Figures . Eliassian: 198 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2509PDF: 769HTML: 5172 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1279HTML: 361PDF: 785 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1878PDF: 1327HTML: 244 -
Pseudo-differentiation syndrome
1275PDF: 631HTML: 10828Figure 1: peripheral blood showing myeloblasts with auer rods: 105Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 93Figure 3: CXR showing pulmonary infiltartes with consolidation: 115Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 92Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 108 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1963PDF: 1576HTML: 344 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3750PDF: 725HTML: 1821 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3421PDF: 2324HTML: 1403 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4633PDF: 1729HTML: 2094 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3619PDF: 1597HTML: 11461Figures Haase: 173 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1859PDF: 702HTML: 677 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3536PDF: 1359HTML: 166 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1669PDF: 921HTML: 126 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1729PDF: 909HTML: 1093Untitled: 136Untitled: 154Untitled: 139Untitled: 144 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3687PDF: 3032HTML: 182 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1685PDF: 846HTML: 357Fig1: 211Fig.2: 228Fig. 3: 159Fig. 5: 165Fig. 4: 196 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2724PDF: 973HTML: 5494 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1173PDF: 547HTML: 2839ATRA induced Reactive Hemophagocytosis: A Case Report: 171 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1723PDF: 776HTML: 10202Figures 1,2,3: 150 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1250PDF: 868Suppl. Files: 428HTML: 215 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
859PDF: 424HTML: 62 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7186PDF: 2345HTML: 1700Table 1.: 182Table 2.: 198Table 3.: 179Table 4.: 178 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1178PDF: 830HTML: 1092Coverletter: 172 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3405PDF: 833HTML: 1620figure 1: 148Untitled: 169 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13171PDF: 928HTML: 7269 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1212PDF: 512HTML: 22989 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2034PDF: 830HTML: 293 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1683PDF: 497HTML: 16955Figure 4: 144Figure 3: 125Figure 2: 124Figure 1: 154 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1222PDF: 765HTML: 111 -
-
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
952PDF: 1074Suppl. Files: 550HTML: 71 -







